Jeffrey Glenn receives $69 million grant
Stanford Medicine’s SyneRx will develop drugs to fight viral pathogens with high pandemic potential, including the one that causes COVID-19.
1,000+genes linked to severe COVID-19
Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.
COVID-19 brain fog similar to chemo brain
Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.
Graduates celebrate in person again
Doctoral, medical and physician assistant students hear messages of hope and compassion as they celebrate graduation.
Awards celebrate teaching, patient care
More than 40 awards were given to faculty, staff, residents and students at Stanford Medicine in recognition of their outstanding contributions during the 2021-2022 academic year.
What to know about monkeypox
The monkeypox virus is normally endemic to Africa but has recently been found on other continents. It spreads through prolonged, direct contact with infected people or their bedding, clothing and towels.
Bacteria that digest breast milk in decline
Stanford Medicine researchers and colleagues found that as nations industrialize, a species of bacteria critical in the early development of infant gut microbiomes fades away.
Faculty and staff honored
Nancy Morioka-Douglas is named physician of the year, the new professionalism award is presented in honor of Kelley Skeff, and Erika Schillinger takes home the quality and safety award.
Ketogenic diet helps cells survive stress
Muscle stem cells enter a deep resting state during fasting or when fed a high-fat ketogenic diet, a Stanford-led study finds. This promotes stem cell resilience but slows injury repair.
Addressing AAPI mental health
A panel of mental health experts discuss culturally specific barriers to seeking care, along with ways to improve outreach.